학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 55건 | 목록 1~20
Academic Journal
Beltran-Bless AA; Division of Medical Oncology, Department of Medicine, The University of Ottawa, Ottawa, Canada.; Pond GR; Department of Oncology, McMaster University, Hamilton, Canada.; Bayani J; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Barker SL; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Canada.; Spears M; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Mallon E; Department of Pathology, Glasgow, United Kingdom.; Taylor KJ; Edinburgh Cancer Research, CRUK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.; Hasenburg A; Department of Gynecology and Obstetrics, University Center Mainz, Germany.; Markopoulos C; National and Kapodistrian University of Athens, Medical School, Athens, Greece.; Dirix L; St. Augustinus Hospital, Antwerp, Belgium.; Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.; van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.; Rea DW; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom.; Vandermeer L; Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, Canada.; Hilton J; Division of Medical Oncology, Department of Medicine, The University of Ottawa, Ottawa, Canada; Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, Canada.; Bartlett JMS; Edinburgh Cancer Research, CRUK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.; Clemons M; Division of Medical Oncology, Department of Medicine, The University of Ottawa, Ottawa, Canada; Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, Canada. Electronic address: mclemons@toh.ca.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Academic Journal
Goodwin PJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Gelmon KA; Department of Medicine, University of British Columbia, BC Cancer Agency, Vancouver, Canada.; Whelan TJ; Department of Radiation Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Ennis M; Applied Statistician, Markham, Ontario, Canada.; Lemieux J; Department of Hematology Research, CHU de Québec-Université Laval, Québec, Québec, Canada.; Ligibel JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hershman DL; Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.; Mayer IA; Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Hobday TJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Bliss JM; Division of Clinical Studies, ICR-CTSU, Institute of Cancer Research United Kingdom, London, United Kingdom.; Rastogi P; Department of Medicine, NRG Oncology and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.; Rabaglio-Poretti M; Department of Medical Oncology, IBCSG and Department of Oncology, Bern University Hospital, University of Bern, Berne, Switzerland.; Mukherjee SD; Department of Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario, Canada.; Mackey JR; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada.; Abramson VG; Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Oja C; Department of Medicine, University of British Columbia, BC Cancer Agency, Vancouver, Canada.; Wesolowski R; Department of Internal Medicine, James Cancer Hospital, Ohio State Comprehensive Cancer Center, Columbus, Ohio.; Thompson AM; Department of Surgery, Baylor College of Medicine, Houston, Texas.; Rea DW; School of Cancer and Genomic Science, Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Stos PM; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Shepherd LE; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Stambolic V; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
Academic Journal
Goodwin PJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Department of Medicine, University of Toronto, Toronto, ON, Canada. Pamela.Goodwin@sinaihealthsystem.ca.; Dowling RJO; Hoffman-La Roche Limited, Mississauga, ON, Canada.; Ennis M; Applied Statistician, Markham, ON, Canada.; Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Shepherd LE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Burnell MJ; Department of Oncology, Saint John Regional Hospital, St. John, NB, Canada.; Vander Meer R; Department of Oncology, Niagara Health System, St. Catharines, ON, Canada.; Molckovsky A; Department of Medical Oncology, Grand River Regional Cancer Centre, Kitchener, ON, Canada.; Gurjal A; Abbotsford Centre, British Columbia Cancer Agency, Abbotsford, BC, Canada.; Gelmon KA; University of British Columbia, BC Cancer Agency, Vancouver, BC, Canada.; Ligibel JA; Dana-Farber Cancer Institute, Boston, MA, USA.; Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Columbia, NY, USA.; Mayer IA; Vanderbilt University, Nashville, TN, USA.; Whelan TJ; McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada.; Hobday TJ; Mayo Clinic, Rochester, MN, USA.; Rastogi P; NRG Oncology and University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Rabaglio-Poretti M; IBCSG and Department of Oncology, Bern University Hospital, University of Bern, Berne, Switzerland.; Lemieux J; CHU de Québec-Université Laval, Québec, QC, Canada.; Thompson AM; Baylor College of Medicine, Houston, TX, USA.; Rea DW; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Stambolic V; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Goodwin PJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Department of Medicine, University of Toronto, Toronto, ON, Canada.; Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Gelmon KA; University of British Columbia, BC Cancer Agency, Vancouver, BC, Canada.; Whelan TJ; McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada.; Ennis M; Applied Statistician, Markham, ON, Canada.; Lemieux J; CHU de Québec-Université Laval, Québec, QC, Canada.; Ligibel JA; Dana-Farber Cancer Institute, Boston, MA.; Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.; Mayer IA; Vanderbilt University, Nashville, TN.; Hobday TJ; Mayo Clinic, Rochester, MN.; Bliss JM; ICR-CTSU, Institute of Cancer Research (UK), London, United Kingdom.; Rastogi P; NRG Oncology and University of Pittsburgh Medical Center, Pittsburgh, PA.; Rabaglio-Poretti M; IBCSG and Department of Oncology, Bern University Hospital, University of Bern, Berne, Switzerland.; Thompson AM; Baylor College of Medicine, Houston, TX.; Rea DW; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Stos PM; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Shepherd LE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Stambolic V; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Roseweir AK; School of Medicine, University of Glasgow, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Bennett L; School of Medicine, University of Glasgow, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Dickson A; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cheng K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Quintayo MA; Ontario Institute of Cancer Research, MaRS Institute, Toronto, Canada.; Bayani J; Ontario Institute of Cancer Research, MaRS Institute, Toronto, Canada.; McMillan DC; School of Medicine, University of Glasgow, Glasgow, UK.; Horgan PG; School of Medicine, University of Glasgow, Glasgow, UK.; van de Velde CJH; Leiden University Medical Centre, Leiden, the Netherlands.; Seynaeve C; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Hasenburg A; University Hospital Mainz, Mainz, Germany.; Kieback DG; Helios Medical Centre, Schleswig, Germany.; Markopoulos C; Athens University Medical School, Athens, Greece.; Dirix LY; St Augustinus Hospital, Antwerp, Belgium.; Rea DW; University of Birmingham, Birmingham, UK.; Mallon EA; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.; Bartlett JMS; Ontario Institute of Cancer Research, MaRS Institute, Toronto, Canada.; Edwards J; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst
Academic Journal
Xu K; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Bayani J; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Mallon E; Department of Pathology, Glasgow, United Kingdom.; Pond GR; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.; Piper T; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom.; Hasenburg A; Department of Gynecology and Obstetrics, University Center Mainz, Mainz, Germany.; Markopoulos CJ; National and Kapodistrian University of Athens Medical School, Athens, Greece.; Dirix L; Oncology Center, St. Augustinus Hospital, Antwerp, Belgium.; Seynaeve CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; van de Velde CJH; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Rea DW; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom.; Bartlett JMS; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom. Electronic address: john.bartlett@ed.ac.uk.
Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE
Academic Journal
Bartlett JMS; University of Edinburgh, Edinburgh, United Kingdom.; Ontario Institute of Cancer Research, Ontario, Canada.; Sgroi DC; Massachusetts General Hospital, Boston, Massachusetts.; Treuner K; Biotheranostics, Inc., San Diego, California.; Zhang Y; Biotheranostics, Inc., San Diego, California.; Piper T; University of Edinburgh, Edinburgh, United Kingdom.; Salunga RC; Biotheranostics, Inc., San Diego, California.; Ahmed I; University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom.; Doos L; University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom.; Thornber S; University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom.; Taylor KJ; University of Edinburgh, Edinburgh, United Kingdom.; Brachtel EF; Massachusetts General Hospital, Boston, Massachusetts.; Pirrie SJ; University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom.; Schnabel CA; Biotheranostics, Inc., San Diego, California.; Rea DW; University of Birmingham, Cancer Research UK Clinical Trials Unit, Birmingham, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Rea, Daniel W
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어